Massive Bone Loss about the Elbow



Massive Bone Loss about the Elbow


Bernard F. Morrey

Joaquin Sanchez-Sotelo



Because the elbow is a subcutaneous joint and vulnerable to trauma and infection and less so malignant conditions, massive loss of bone and soft tissue about the elbow is relatively common and constitutes a devastating problem (1). This probably represents the most challenging of all interventions about the elbow. The salvage treatment is either implant or nonimplant salvage (2,3,4,5).




CONTRAINDICATIONS



  • Active or acute sepsis


  • Prior sepsis with potential to be subacute (exclude with staged procedure)


  • Absence of neural function of the hand


  • Absence of potential to flex the elbow if reconstructed


  • Deficiency of soft tissue coverage, until adequately addressed, if possible


  • Inability of patient to cooperate


IMPLANT SALVAGE OPTIONS

The implant salvage option may be either a prosthetic or an allograft replacement. In fact, the most efficient way of managing massive bone loss at the elbow is an allograft prosthetic composite (APC). In recent years, we have refined our thought process and clinical experience and feel as though reliable APC options are now available even for the most devastating circumstances (5).


NONPROSTHETIC MANAGEMENT

The basic approach to nonprosthetic management is that of stabilizing the forearm referable to the humerus. This is often done in the acute setting using an external fixator with the intent to achieve a resection arthroplasty that may have some stability due to the scar tissue. This is usually indicated in instances of gross or refractory infection but the outcome is highly unpredictable and thus is truly the final salvage option (6).


RECONSTRUCTION OPTIONS

There are four forms of functional reconstruction: osteoarticular allograft, allograft augmentation, impaction grafting, and allograft prosthetic composite. We regularly employ two methods of reconstructing massive bone loss at the elbow: allograft augmentation, that is, the use of struts and APC. Impaction cancellous grafting is used when there is adequate circumferential albeit expanded, cortex available and is not discussed here (1,7).







FIGURE 35.1 An osteoarticular allograft reconstruction of the elbow demonstrates neuropathic changes 10 years after insertion (A,B). This was successfully revised with a linked Coonrad/Morrey implant and a Type 2 APC for both the humerus and the ulna (C,D). (Arrows in D depict the strut of the APC.)


Osteoarticular Allograft

Osteoarticular allograft reconstruction of the elbow has not proven effective long-term due to the inevitable development of neuropathic degeneration (2) (Fig. 35.1).







FIGURE 35.2 A patient with failed distal humeral fracture fixation but reasonable host bone is an ideal candidate for an allograft strut without the need for an APC.


Allograft Augmentation








CONTRAINDICATIONS



  • Recent sepsis.


  • Nonfunctional hand.


  • Lack of motor power to flex the elbow.

Note: Loss of extension power can be compensated by gravity and is not an absolute contraindication.



  • Simpler solutions exist (i.e. direct recementation and use of struts) (Fig. 35.4).


STRUT RECONSTRUCTION


Technique

Patient positioning The patient is supine on the table. The arm is brought across the chest (Fig. 35.5A).


Incision



  • A posterior skin incision is employed in the majority of instances. As this is often a salvage procedure, prior incisions are followed.


  • Typically wide and thick subcutaneous tissue flaps are raised both medially and laterally but only to the extent needed for the reconstruction (Fig. 35.5B).






FIGURE 35.4 Failed custom device with loss of distal humeral bone (A). Easily reconstructed with recementation of a long flanged device with an anterior strut (arrow) (B,C).







Get Clinical Tree app for offline access